For CEOs and CFOs of public microcap companies, the litigation climate is changing…and not in your favor. The latest NERA and Cornerstone Research H1 2025 Securities Class Action Reports confirm that while filing volume remains steady, the type of cases and the size of losses are escalating.
The new frontline of securities litigation? Artificial Intelligence (AI), cryptocurrency, and cases producing massive market capitalization losses (DDL and MDL).
Want a deeper dive into the data from these reports as they relate to your company’s risk profile and coverage limits? CLICK HERE to test Churchwell Insurance’s beta GPT that will help you understand your company’s risk profile and recommended limits of coverage utilizing current litigation data, EDGAR filings, and public peer D&O analytics.
AI and Crypto: The New Litigation Epicenters
Microcaps in emerging industries like AI and blockchain/crypto are increasingly vulnerable. These companies often rely on innovation and bold projections to attract investors. That same excitement is what plaintiffs’ attorneys weaponize when expectations don’t meet reality.
• AI-related cases: 12 filings in H1 2025, nearly matching the 15 filed in all of 2024.
• Crypto-related cases: 6 filings in just six months, almost equaling the prior full-year total.
The lesson? Hype cycles create fertile ground for securities lawsuits. If your company makes forward-looking claims about technology, adoption, or partnerships, plaintiffs are watching.
Example: An AI microcap touts breakthrough algorithms that never reach commercialization. Investors sue, alleging misstatements about capabilities and market readiness.
Understanding DDL and MDL: Why They Matter
The Cornerstone Report highlights the growing significance of mega filings measured by Disclosure Dollar Loss (DDL) and Maximum Dollar Loss (MDL).
• Disclosure Dollar Loss (DDL): Measures market cap decline directly tied to a corrective disclosure during the class period.
o Example: A microcap biotech valued at $200M discloses failed trial results. Stock plummets to $120M. The $80M decline becomes the DDL.
• Maximum Dollar Loss (MDL): Tracks the drop from the highest market cap during the class period to the post-disclosure low, regardless of other factors.
o Example: The same biotech peaks at $240M before disclosure, then bottoms at $120M. The $120M drop is the MDL.
Both metrics illustrate how plaintiffs quantify harm and why even microcaps face existential threats.
In H1 2025, there were 15 mega DDL filings, three times the long-term average. While microcaps rarely lose billions, their proportional losses (e.g., a 50–70% overnight drop) can be just as devastating. This means your size doesn’t protect you…it magnifies your vulnerability.
SPACs Remain in the Crosshairs
Though SPAC activity has cooled, 5 SPAC-related filings in H1 2025 prove plaintiffs are not moving on. Post-merger underperformance, governance lapses, and disclosure gaps remain high-risk triggers. For microcaps that entered the market via SPAC, strong 1933 Act coverage is non-negotiable.
Why Microcaps Are Uniquely Exposed
• Thin Compliance Resources: Most microcaps lack robust legal and disclosure infrastructure.
• Volatile Market Caps: Sudden swings are magnets for litigation.
• Investor Sensitivity: Small guidance misses or trial setbacks can spark outsized reactions.
• Aggressive Plaintiffs: Lower dismissal rates mean more cases reach discovery, driving defense costs into the millions.
What Microcap Executives Must Do Now
At Churchwell Insurance, we help public microcaps address these risks before they become claims by:
• Running complimentary public D&O program audits (under NDA when a fit)
• Ensuring 1933 Act coverage is properly included and exclusions removed
• Aligning policy limits to real-world loss scenarios, not just paper adequacy
• Leveraging up-to-date litigation analytics to benchmark risk exposure
Final Thought
For public microcap CEOs and CFOs, the data is clear: AI, crypto, and mega-loss cases are reshaping securities litigation. Plaintiffs are sharper, losses are bigger, and dismissals are harder to secure.
The right D&O insurance program isn’t a checkbox…it’s a survival tool. Don’t wait until your board is staring at a seven-figure defense bill to realize the gaps. Get your policy reviewed now and protect your leadership team before it’s too late.
Learn more about your company’s risk and data driven limit recommendations using the Churchwell Insurance Micro-Cap Public D&O Coverage Calculator, then call our team to discuss — +1 844.604.1357
Disclaimer: This article is for informational purposes only and does not constitute legal or insurance advice. Companies should consult qualified legal counsel and experienced insurance professionals for decisions regarding securities litigation risk and executive liability coverage.
Sources:
– Cornerstone Research, Securities Class Action Filings: 2025 Midyear Assessment
– NERA , Recent Trends in Securities Class Action Litigation: H1 2025 Update
– The D&O Diary, Securities Suit Filings Steady in Year’s First Half
– JD Supra, Key Trends in Federal Securities Class Action Filings: H1 2025
